Cupertino, CA, United States of America

Laxminarayan Bhat

USPTO Granted Patents = 39 


 

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 202(Granted Patents)


Location History:

  • San Jose, CA (US) (2012 - 2013)
  • Santa Clara, CA (US) (2005 - 2019)
  • Cupertino, CA (US) (2011 - 2024)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
Loading Chart...
39 patents (USPTO):Explore Patents

Title: Laxminarayan Bhat: An Innovator in Pulmonary Treatments

Introduction

Laxminarayan Bhat is a distinguished inventor based in Cupertino, California, known for his significant contributions in the field of pharmaceuticals. With an impressive portfolio of 39 patents, he has emerged as a prominent figure in the development of innovative treatments for pulmonary diseases.

Latest Patents

Among his latest inventions, Bhat has patented methods for treating pulmonary fibrosis and pulmonary hypertension. The method for treating pulmonary fibrosis involves the use of arylpiperazine derivatives, specifically through the administration of a compound of Formula 1 to patients in need. Similarly, his method for treating pulmonary hypertension also utilizes arylpiperazine derivatives, providing essential therapeutic options for patients suffering from these challenging conditions.

Career Highlights

Laxminarayan Bhat has built a remarkable career, contributing his expertise to notable companies such as Reviva Pharmaceuticals and Xenoport. His work in these organizations has been instrumental in advancing the development of pharmaceutical innovations, particularly in addressing complex health issues related to pulmonary diseases.

Collaborations

Throughout his career, Bhat has collaborated with talented professionals like Kouacou Adiey and Prabhu Prasad Mohapatra. These partnerships have fostered a dynamic and innovative environment, leading to significant advancements in the pharmaceutical field.

Conclusion

Laxminarayan Bhat's contributions to medical science through his patents and collaborations exemplify the spirit of innovation. His work not only highlights the potential of arylpiperazine derivatives in treating serious lung conditions but also showcases the importance of collaboration in driving meaningful advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…